MS Speaks

Multiple Sclerosis => TREATMENTS => MAYZENT (siponimod) => Topic started by: agate on January 29, 2020, 09:35:32 pm

Title: European Commission approves Mayzent for active SPMS
Post by: agate on January 29, 2020, 09:35:32 pm

From the European Pharmaceutical Review (January 29, 2020), "European Commission Approves Mayzent for [Active] Secondary Progressive Multiple Sclerosis":

https://www.europeanpharmaceuticalreview.com/news/111603/ec-approves-mayzent-for-secondary-progressive-multiple-sclerosis/